WM88Homo sapiens (Human)Cancer cell line

Also known as: WC00123, WM 88, WM-88

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_6805
SpeciesHomo sapiens (Human)
Tissue SourceNot specified

Donor Information

Age CategoryUnknown
SexMale

Disease Information

DiseaseMelanoma
LineageSkin
SubtypeMelanoma
OncoTree CodeMEL

DepMap Information

Source TypeAcademic lab
Source IDACH-000899_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
10,13
D16S539
11,13
D18S51
15,19
D19S433
12,13
D21S11
29,30
D2S1338
19
D3S1358
15
D5S818
12,13
D7S820
8,10
D8S1179
13,15
FGA
20,21
TH01
9.3
TPOX
12
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.

Rosen N., Solit D.B.

Cancer Res. 74:2340-2350(2014).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression.

Nathanson K.L.

Cancer Res. 68:5743-5752(2008).

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Dummer R.

Pigment Cell Res. 19:290-302(2006).

Web Resources